11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Veristat is pleased to participate in PHUSE EU Connect 2026, November 16–17, bringing together clinical data, statistical programming, and regulatory professionals to explore new approaches to managing data, improving processes, and advancing clinical development.
As clinical trial disclosure requirements evolve, sponsors face growing pressure to balance transparency, patient privacy, and regulatory compliance. Veristat brings more than 30 years of clinical development and regulatory experience to help sponsors anticipate requirements, reduce rework, and prepare high-quality submissions.
During the conference, Veristat’s Honz Slipka will present “Conflict & Convergence for Accelerated Disclosure of Clinical Documents,” exploring how integrating disclosure considerations earlier in clinical development can streamline anonymization, minimize repeated redaction cycles, and better align the expectations of regulators, sponsors, and the public.
Meet With Us
Connect with Veristat to discuss your medical writing, regulatory strategy, and global submission needs. Our team looks forward to sharing how integrated expertise can help strengthen submission readiness and advance your development goals.
Attending: Honz Slipka, Veristat Associate Principal Transparency Specialist
Schedule a Meeting in Advance
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy.
Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
Meet with us at PHUSE EU 2026 by filling out the form below.
11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...